文献速递乳腺乳腺X线US

立体定向真空辅助针芯活检对乳腺X线摄影中非钙化病灶的结局

Stereotactic Vacuum-Assisted Needle Biopsy Outcomes of Non-calcified Mammographic Lesions.
PubMed 文献 · Acad Radiol · 2020-08-08

该回顾性研究分析了2014年至2017年间在本机构因超声隐匿、乳腺X线摄影发现的非钙化病灶而行立体定向真空辅助大孔径活检的222个病灶,其中5.9%为恶性,显著低于同期钙化灶的19.0%(p<0.001)。整合年龄>50岁、病灶类型和大小<15 mm的多变量Logistic回归模型AUC为0.89,可避免82%的不必要活检。

要点

  • 非钙化病灶立体定向活检的恶性率为5.9%,低于同期钙化灶的19.0%(p<0.001)。
  • 所有不对称(42个)和结构扭曲(33个)均为良性,肿块和局灶性不对称的恶性率分别为8.7%和8.9%。
  • 年龄>50岁、病灶类型和大小<15 mm的模型AUC为0.89,最高PPV为0.24,可避免82%的不必要活检。

核心结论

  • 非钙化病灶在立体定向引导下活检的恶性检出率低(5.9%);整合年龄、病灶大小和类型的多变量模型可能有助于在本队列中避免不必要的活检。

研究设计与样本

  • IRB批准的回顾性研究,纳入2014年1月1日至2017年12月31日在本机构因超声隐匿、乳腺X线摄影发现的非钙化病灶行立体定向真空辅助大孔径活检的222个病灶(213例患者),比较患者年龄、病灶类型、大小和位置与病理结局(良性、高危或恶性),使用Wilcoxon-Mann-Whitney或Fisher精确检验,并建立多变量Logistic回归模型,以ROC曲线和AUC评估诊断效能。

诊断标准与关键数值

  • 非钙化病灶恶性率为5.9%(13/222),良性79.3%(176/222),高危14.9%(33/222)。
  • 同期钙化灶活检的恶性率为19.0%(243/1279),非钙化病灶较钙化灶恶性可能性更低(p<0.001)。
  • 所有不对称(42个)和结构扭曲(33个)均为良性;肿块恶性率8.7%(4/46),局灶性不对称恶性率8.9%(9/101)。
  • 与良性/高危病灶相比,恶性病灶与年龄更大(平均65.2岁 vs 52.7岁,p<0.001)、病灶更小(平均9.5 mm vs 15.5 mm,p<0.01)和并发乳腺癌(p<0.01)相关。
  • 使用年龄>50岁、病灶类型和大小<15 mm的多变量Logistic回归模型AUC=0.89(95%CI 0.83,0.94),PPV最高为0.24(95%CI 0.13,0.38),避免的不必要活检数量最多(172/209,82%)。

临床应用与阅片要点

  • 作者认为,整合年龄、病灶大小和类型的多变量模型可能有助于在本队列中避免不必要的活检。

局限性

  • 原文为回顾性研究。
  • 原文结论指出模型可能有助于避免不必要的活检,尚需进一步研究(原文:could potentially help avoid unwarranted biopsies)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To identify the outcomes of stereotactic vacuum-assisted large bore biopsies performed on sonographically-occult non-calcified mammographic lesions (NCL).

MATERIALS AND METHODS: In an IRB-approved retrospective study, we reviewed all NCL that underwent stereotactic biopsy from January 1, 2014 to December 31, 2017 at our institution, comparing patient age, lesion type, size and location with pathology outcome (benign, high-risk or malignant) using Wilcoxon-Mann-Whitney or Fisher's exact tests as appropriate. Multivariable logistic regression models were developed to decrease benign biopsies in our cohort with diagnostic performance assessed using receiver operating characteristic curve and area under the curve (AUC).

RESULTS: Of 222 biopsied lesions in 213 patients, 79.3% (176/222) were benign, 5.9% (13/222) malignant, and 14.9% (33/222) high-risk. NCL were less likely to be malignant compared to calcifications biopsied in the same period [5.9% vs 19.0% (243/1279), p < 0.001]. All 42 asymmetries and 33 architectural distortions were benign, while 8.7% (4/46) of masses and 8.9% (9/101) of focal asymmetries were malignant. Cancers were associated with older age (mean 65.2 vs 52.7 years, p < 0.001), smaller size (mean 9.5 mm vs 15.5 mm, p < 0.01), and concurrent breast cancer (p < 0.01) compared to benign/high-risk lesions. Multivariable logistic regression model using patient age >50 years, lesion type, and size <15 mm had a high diagnostic performance [AUC=0.89, 95%CI (0.83, 0.94)], and yielded the highest PPV [0.24; 95%CI (0.13, 0.38)], and highest number of avoided, unnecessary biopsies (172/209, 82%).

CONCLUSION: NCL biopsied under stereotactic guidance have low cancer yield (5.9%). A multivariate model integrating age, lesion size and type could potentially help avoid unwarranted biopsies in our cohort.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Porembka JH, Compton L, Schmidt S, et al. Stereotactic Vacuum-Assisted Needle Biopsy Outcomes of Non-calcified Mammographic Lesions. Acad Radiol. 2020. PMID: 32782221. doi:10.1016/j.acra.2020.07.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。